(T 10) Safety and Tolerability of Anti-PACAP Monoclonal Antibody Lu AG09222 when Co-administered with a Gepant in Participants with Migraine

Presenting Author(s)

Amaal J. J. Starling, MD

Associate Professor of Neurology
Mayo Clinic Arizona
Scottsdale, Arizona, United States

Jessica Ailani, MD

Director Medstar Georgetown Headache Center, Associate Professor Neurology
Department of Neurology, Georgetown University Hospital
Washington, DC, United States
IF

Ioana Florea, n/a

H. Lundbeck A/S
Copenhagen, Hovedstaden, United States
CG

Charlotte Granhall, n/a

H. Lundbeck A/S, United States
KF

Katrine Falkenberg, n/a

H. Lundbeck A/S, United States
PE

Peter Eriksen, n/a

H. Lundbeck A/S, United States
EL

Elin Löf, n/a

H. Lundbeck A/S, United States
LP

Line Pickering Boserup, MD, PhD

H. Lundbeck A/S
Copenhagen, Hovedstaden, United States
OM

Ole Michael Lemming, n/a

H. Lundbeck A/S, United States
Messoud Ashina, n/a

Professor of Neurology and Chief Physician
Copenhagen University Hospital–Rigshospitalet
Glostrup, Hovedstaden, United States